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astrocytes of the forebrain (Reuss et al., 2003). Possibly, as a
consequence of altered intermediate filament architecture in
astroglial cells abutting brain capillaries, mice lacking FGF-
2 have a leaky blood–brain barrier. Given the crucial role of
astroglial cells for neuronal homeostasis, maintenance, and
regeneration (see Hatten et al., 1991; Kirchhoff et al., 2001
for reviews), alterations in astroglial functions seen in FGF-
2-deficient mice might well result in compromised recovery
following brain ischemia. This notion is further supported
by the established role of FGF-2 in upregulating major
neurotrophic and neuroprotective cytokines in cultured
and reactive astroglial cells. These include, for example,
nerve growth factor (NGF) and GDNF (Suter-Crazzolara
and Unsicker, 1996; Yoshida and Gage, 1991).
Brain-derived neurotrophic factor (BDNF) is a potent
neurotrophin with both acute roles in synaptic plasticity and
morphological and functional recovery in the lesioned
nervous system (Gacek et al., 1998; Kafitz et al., 1999;
Korte et al., 1995; Saarelainen et al., 2000). It signals
through the receptor tyrosine kinase trkB (see Klein, 1994;
Malcangio and Lessmann, 2003 for reviews). BDNF, which
is upregulated in the adult brain along with its cognate
receptor trkB following cerebral ischemia (cf. Lindvall et
al., 1992; Merlio et al., 1993), has also been shown to rescue
hippocampal neurons after transient forebrain ischemia in
rats (Wu and Pardridge, 1999). BDNF given intraventricu-
larly before, and intraparenchymal infusion of BDNF fol-
lowing focal cerebral ischemia significantly reduce infarct
volume (Beck et al., 1994; Scha ¨bitz et al., 1997). Interest-
ingly, FGF-2 has been shown to upregulate trkB mRNA
(Brumwell et al., 2000) suggesting that BDNF and trkB may
respond jointly to FGF-2. We have therefore examined
whether regulation of BDNF and trkB is altered in cerebral
ischemia depending on the presence or absence, respective-
ly, of FGF-2. We find that mice lacking FGF-2 have a larger
infarct volume compared to wild type littermates. Loss of
FGF-2 is accompanied by a lack of ischemia-mediated
induction of BDNF and trkB mRNA in the hippocampus.
This suggests a crucial role of FGF-2 in the lesion-depen-
dent upregulation of these important constituents of the
brain’s signaling network that ascertains neuron survival.
Materials and methods
Animals
fgf2/ knock-out mice used for the present study were
of the strain generated in a 129Sv:C57BL/6 background by
Dono et al. (1998). Animals used for the experiments were
mainly derived from heterozygous crosses. Wild type litter-
mates were used as control animals. Mice were examined at
3 to 5 months of age.
The experiments were performed on 76 animals, includ-
ing MCAO, RT-PCR, and in situ hybridization techniques.
The animals with inadequate Laser Doppler exponent (nine
mice) and animals that died during surgery (six mice) were
excluded from data analysis.
Surgical procedures of the middle cerebral artery occlusion
(MCAO)
The MCAO procedure has been described before (Herr-
mann et al., 2003; Schneider et al., 1999). Briefly, mice
were anaesthetized with 1% halothane in 33% O2 and 66%
N2O. Rectal temperature was monitored continuously and
maintained at 37 F 0.5jC by external heating. For contin-
uous monitoring of arterial blood pressure and blood gases,
the left femoral artery was cannulated with polyethylene
tubing in subgroup of mice. For laser Doppler measure-
ments, the probe (P403; Perimed, Ja ¨rfa ¨lla, Sweden) was
placed 3 mm lateral and 6 mm posterior to the bregma.
Relative perfusion units were obtained (Periflux 4001;
Perimed, Ja ¨rfa ¨lla, Sweden). The left carotid region was
exposed through a midline skin incision. A 5–0 nylon
filament (Ethilon, Norderstedt, Germany) with a blunted
tip was inserted into the common carotid artery and ad-
vanced into the internal carotid until the laser Doppler signal
decreased considerably. After 15 min of occlusion, the
filament was removed. After 3 h up to 24 h of reperfusion,
mice were deeply anesthetized with Rompunk/Ketanestk
and perfused with saline (Ringer) or 4% paraformaldehyde
(PFA) in phosphate-buffered saline (PBS). All animal
experiments were performed and approved in accordance
with the German law.
Monitoring of neurological status
At day 1 (24 h after MCAO), all surviving animals were
examined neurologically using an established scoring sys-
tem first introduced by Bederson et al. (1986). Contralateral
motor deficits of the upper limp were considered as an effect
of MCAO.
Mortality
Mortality was defined as animals that died up to 24
h after transient MCA occlusion. The animals that died
during surgery (bleeding, problems due to anesthesia) were
excluded from data analysis.
Assessment of infarct volume
Twenty four hours after the onset of MCAO mice were
perfused, the brains were removed and immediately frozen
on dry ice. Coronal cryosections (20 Am) were cut at 400 Am
intervals, starting rostrally. Sections were stained with a
silver staining technique, which was shown to be equivalent
to other common staining techniques for detecting infarcted
tissue (Vogel et al., 1999). Stained sections were directly
scanned at 600 dpi and the infarct area was measured (Scion
Image, USA). The total infarct volume was obtained by
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(Swanson et al., 1990). Mice without infarct were excluded
from the analysis, as this correlated with a low laser Doppler
drop during ischemia (more than 25% of perfusion retained)
and was probably due to an inadequate position of the nylon
filament. Although a 24-h observation period has been
shown in an animal model to be sufficient for full infarct
maturation (Connolly et al., 1996), we also monitored
animals after 48 h ischemia. Since only wild types were
observed longer as 1 day after ischemia, these observations
were not included in the study.
In situ hybridization
Mice were perfused with 4% PFA. Brains were removed
from the skull and frozen on dry ice. Cryosections (12 Am)
were cut on a cryostat and mounted on Superfrost slides.
Non-radioactive in situ hybridization (ISH) was carried
out as described by Ernsberger et al. (1997). Dig-labeled
riboprobes were synthesized from cDNA fragments for
murine BDNF (646 bp) and trkB (740 bp) generated by
PCR from mouse brain cDNA. The plasmid was appropri-
ately linearized and transcribed with Sp6 and T7 for
antisense probe and sense control, respectively. The struc-
tures of the BDNF and trkB cDNA probes were as follows:
BDNF antisense probe-CTTATGAATCGCCAGCCAAT,
BDNF sense control-GCGCCCATGAAAGAAGTAAA;
trkB antisense probe-TACCCATCCAGTGGGATCTTA,
trkB sense control-TGGCTGAAGTGGCATGGA.
For the quantification of ISH, images were made using a
software-controlled (Axiovision 3.0; Zeiss, Germany) digi-
tal camera (Axiocam, Zeiss) attached to a microscope
(Axioplan imaging; Zeiss). For all images, the same para-
meters were used (e.g., illumination time, threshold). Images
Fig. 1. Increased FGF-2 expression in parietal cortex and hippocampus following MCAO in wild type (FGF-2 (+/+)) mice. (A) Qualitative PCR determination
of FGF-2 mRNA in the ipsilateral hippocampal formation and parietal cortex at 3 h following MCAO or sham surgery, respectively. Representative data are
shown. Note the increase in FGF-2 mRNA in response to MCAO. The size of the FGF-2 amplicon is 455 bp, h-actin amplicon-182 bp. (B) Quantification of
FGF-2 mRNA in parietal cortex and hippocampal formation at 3 and 24 h after MCAO by real-time PCR. Values are expressed relative to cyclophilin mRNA.
Values are the means F SEM of 4 per group determined in triplicate. *P < 0.05, **P < 0.01.
Fig. 2. Infarct volume and histology. (A) Histology of coronal silver-stained sections from brains of an FGF-2 (+/+), (wild type, wt), and an FGF-2 (/)
(FGF2 KO) mouse after 24 h of ischemia. White areas indicate ischemic tissue. (B) Quantification of infarct volumes of the ipsilateral hemispheres in mm
3
were made from 10 animals in each group. Values are given as the mean F SEM and compared by unpaired two-tailed t test. *P < 0.05.
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measurements were done using ImageJ (NIH, USA). The
color-images were changed to 8-bit grayscale images that
were represented using unsigned integers in the range 0–
255 (256 different gray values, coding for intensities). In
each converted image, histograms of the distribution of
pixel intensities were made. The mean intensity values were
calculated for a specific region of interest (for further
details, see also von Bohlen und Halbach et al., 2002),
which was defined to cover the area of either the pyramidal
layer of the hippocampus, or in the case of the dentate
gyrus, the granular layer, as described earlier).
RT-PCR
The ipsilateral hippocampal formation and parietal cortex
were prepared from Ringer-perfused brains and immediately
frozen on dry ice. Tissues were homogenized under liquid
nitrogen and RNA was extracted with Tri-Fast (Invitrogen,
Germany). Synthesis of cDNA was done with 1 Ag of total
RNA, M-MLV-RT (Promega, Heidelberg, Germany) and
oligo-dT18 (New England Labs, Frankfurt, Germany). For
qualitative PCR equal amounts of cDNA were used in a set
of PCR reactions with a set of primers to amplify h-actin
cDNA (5V -primer: 5V -TCATGAAGTGTGACGTTGA-
CATCCGT-3V ;3 V -primer:5V CCTAGAAGCATTTGC-
GGTGCACGATG-3V ) as a house-keeping-gene and a set
of primers to amplify FGF-2 cDNA (5V -primer: 5V -
ATCACCTCGCTTCCCGCA-3V 3V -primer: 5V -TCAG-
CTCTTAGCAGACATTGG-3V ). For quantitative real-time
PCR, serial dilutions of cDNA were amplified in parallel
with primers for cyclophilin (5V -primer: 5V -ACCCCA-
CCGTGTTCTTCGAC-3V ;3 V -primer: 5V -CATTTGCCA-
TGGACAAGATG–3V ) as internal standards and FGF-2
(5V -primer: 5V -ATCACCTCGCTTCCCGCA-3V 3V -primer:
5V -TCAGCTCTTAGCAGACATTGG-3V ) with the SYBR-
Green-Kit in GeneAmp-Cycler equipped with GeneAmp
5700SDS software (all from PE Biosystems).
Data analysis
Quantitative data were expressed as the mean F standard
deviation (SD) or standard error of the mean (SEM) from at
least three experiments. ANOVA (Student–Newman–Keuls
post hoc test) and Student’s t test were used for statistical
analysis (Prism 3.0, Graphpad, USA); P values less than
0.05 were considered as being significant. Neurological
scores were evaluated by nonparametric statistical proce-
dures. Survival differences between groups were tested
using contingency analysis with the chi-square statistics.
Results
FGF-2 mRNA is increased following MCAO
Using RT-PCR increased FGF-2 mRNA accumulation
was found in parietal cortex and hippocampus of normal
mice (FGF-2 (+/+)) ipsilaterally to the MCA occlusion after
3 h of reperfusion compared to sham-operated animals (Fig.
1A). At 24 h, there was a significant further increase
in FGF-2 mRNA in both areas (Fig. 1B). Together, these
data suggest a progressive upregulation in FGF-2 mRNA
accumulation during the initial 24 h following reperfusion.
This is consistent with previous reports that have described
a significant upregulation of FGF-2 after ischemia using
ISH and Northern blot analysis (cf. Lin et al., 1997; Takami
et al., 1992).
Infarct volume is enlarged in mice lacking FGF-2
Twenty-four hours after reperfusion, the total infarction
volume was assessed by volumetric analysis using silver
staining. Fig. 2 shows that total infarct volume was in-
creased by 75% in FGF-2 (/) mice compared to wild
type littermates (71.6 + 10.3 mm
3 compared to 41.3 + 8.3
mm
3, P < 0.05.). Increased sensitivity of FGF-2 null mice to
ischemic brain injury was accompanied by a significant
Table 1
Mortality and neurological deficit after focal ischemia
Genotype Mortality Neuroscore
WT (FGF2+/+) 20.6% (6/29) 2.1 F 0.33 (n = 10)
KO (FGF2/) 46.8% (15/32)* 2.43 F 0.42 (n = 10)
Mortality. Each value represents percent mortality (number of animals that
died up to 24 h after transient MCA occlusion/number of operated animals)
of each genotype. For calculating mortality all animals undergoing MCAO
were counted, except animals with inadequate Laser Doppler exponent and
animals that died during surgery.
Neuroscore. Values are given in relative units according to Bederson et al.
(1986).
*P < 0.05, Chi-square one-tailed test, compared to wt group.
Table 2
Physiological conditions in FGF-2 (+/+) and FGF-2 (/) mice 24 h after
MCAO
MCAO MABP
(mm Hg)
pCO2
(mm Hg)
pO2
(mm Hg)
pH BG
(mg/dt)
FGF-2(+/+) (n = 5)
Before 89 F 53 9 F 61 1 3 F 11 7.34 F 0.06 145.5 F 9.5
During 87 F 44 6 F 59 2 F 13 7.33 F 0.04 217.1 F 43.8
After 93 F 44 3 F 3 120 F 6 7.35 F 0.05 167.0 F 10.1
FGF-2(/)( n=5 )
Before 81 F 64 1 F 49 4 F 15 7.32 F 0.05 132.5 F 21.9
During 89 F 44 9 F 41 1 0 F 14 7.29 F 0.07 178.2 F 32.5
After 97 F 64 5 F 31 1 4 F 11 7.33 F 0.05 161.5 F 48.8
Mice were subjected to transient MCAO followed by reperfusion.
Physiological parameters presented here were measured ‘‘before’’ (prior
to MCAO), ‘‘during’’ (7 min after MCAO), or ‘‘after’’ (20 min of
reperfusion) MCAO. Values are means F SD. n, number of animals.
MABP, mean arterial blood pressure; BG, blood glucose. Differences of
physiological parameters between groups were not statistically significant
(P > 0.05, unpaired t test). There were no differences in body temperature
values either (data not shown).
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no difference in the neurological score between groups
(Table 1).
Table 2 provides evidence that physiological variables,
including mean arterial blood pressure (MABP), pCO2, pO2,
pH, blood glucose (BG), and body temperature (the latter
not shown), showed no significant differences comparing
FGF-2 (+/+) and FGF-2 (/) mice. Along the same line,
Laser Doppler flowmetry provided evidence that CBF
reductions in the ischemic core were not significantly
d i f f e r e n ti nF G F 2( /) compared to wild type mice.
(CBF after MCAO, percent of baseline: wt, 9.0 + 2.6%;
FGF-2 null mutant, 8.5 + 1.7%; P > 0.05, t test; n = 10 per
group).
Induction of hippocampal BDNF and trkB mRNA expression
after MCAO is compromised in FGF-2 null mice
Previous studies have suggested that BDNF and trkB are
upregulated in the ischemic brain (Arai et al., 1996;
Schmidt-Kastner et al., 2001). We therefore investigated
whether FGF-2 was required for mediating ischemia-related
Fig. 4. trkB mRNA in situ hybridization in the hippocampus (A, C, E, G, I)
and CA1 region (B, D, F, H, J): A, B: FGF-2 (+/+) unlesioned, C, D: FGF-2
(+/+), MCAO E, F: FGF-2 (/) unlesioned, G, H: FGF-2 (/), MCAO
I–J: trkB, sense-controls. Scale bars = 100 Am.
Fig. 3. BDNF mRNA in situ hybridization in the hippocampus (A, C, E,
G, I) and CA1 region (B, D, F, H, J): A, B: FGF-2 (+/+) unlesioned, C, D:
FGF-2 (+/+), MCAO E, F: FGF-2 (/) unlesioned, G, H: FGF-2 (/),
MCAO I–J: BDNF sense-controls. Scale bars = 100 Am.
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and C show that BDNF mRNA was prominently increased
24 h after reperfusion in the hippocampal formation of FGF-
2 (+/+) mice. Figs. 3B and D show higher magnifications of
the area CA1. In contrast, FGF-2 null mice failed to show
such an induction of hippocampal BDNF mRNA (Figs. 3E
and G; for higher magnifications of CA1 area—see Figs. 3F
and H). Fig. 4 (A–H) illustrate the trkB expression before
(A, B) and after MCAO (C, D) in FGF-2 (+/+) and FGF-2
(/) mice (E–H). In situ hybridizations for BDNF mRNA
and for trkB mRNA, using sense control probes, are shown
in Figs. 3I, J and Figs. 4I, J, respectively.
Quantitative evaluation of optical densities (Figs. 5A–C)
revealed a significant 50% increase in BDNF mRNA in the
dentate gyrus and pyramidal layer of the hippocampus in
FGF-2 (+/+) mice. This increase was abolished in FGF-2
null mice. Figs. 5D–F demonstrate that trkB mRNA was
also upregulated in FGF-2 (+/+). In FGF-2 (/) mice, trkB
mRNAwas reduced in response to ischemia. Together, these
results indicate that lack of FGF-2 compromises the ische-
mia-mediated upregulation of mRNAs encoding BDNF and
its cognate receptor trkB.
Discussion
Basic fibroblast growth factor (bFGF/FGF-2; Abraham et
al., 1986) is a multifunctional growth factor addressing
many different cell types. FGF-2 participates, alone or in
synergy with other factors, in the control of the proliferation
of neuronal progenitor cells (Vescovi et al., 1993), neuronal
differentiation (Birren and Anderson, 1990) and survival
(Schmidt and Kater, 1995; Unsicker et al., 1987),i o n
channel expression (Shitaka et al., 1996), neurite outgrowth
(Williams et al., 1994), and repair response after injury
(Gomez-Pinilla et al., 1992). FGF-2 has been shown to be
upregulated not only in ischemic brain tissue (Reilly and
Kumari, 1996; Takami et al., 1993; Wei et al., 2000), but
Fig. 5. Quantification (optical density, in situ hybridization) of BDNF mRNA (A–C) and trkB mRNA (D–F) in the hippocampus before and 24 h after MCAO.
Gray scale values are means F SD. Determinations were made on three animals per group and experiments were repeated three times. P < 0.01, ANOVAwith
Student–Newman–Keuls post hoc test. Abbreviations: CA1 = hippocampal field CA1; CA3 = hippocampal field CA3; DG = dentate gyrus.
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induced seizures (Bugra et al., 1994) and fimbria–fornix
transection (Gomez-Pinilla and Cotman, 1992).
In the present study, we provide the first evidence for a
prominent role of endogenous FGF-2 in coping with ische-
mic brain injury using FGF-2 (/) mice subjected to
MCAO. While there were no significant differences in
ischemia-evoked alterations of several important physiolog-
ical parameters, including CBF, blood gases, and blood
glucose, both infarct volume and mortality were markedly
i n c r e a s e di nF G F - 2( /) mice compared to wild-type
littermates. We observed a slight yet not significant decrease
in blood pressure in our FGF-2 (/) mice suggesting that a
difference in vascular tone may not contribute to the
differential outcome of ischemia in FGF-2 (+/+) and FGF-
2( /) mice.
Several mechanisms have been proposed to explain the
beneficial effects of FGF-2 in brain ischemia. Among these
mechanisms are (i) suppression of glutamate-induced ele-
vation of intracellular calcium concentrations and free
radical formation, (ii) downregulation of expression of the
NMDA receptor-glutamate-binding subunit (Mattson et al.,
1993), (iii) induction of the glial cell line-derived neuro-
trophic factor (GDNF) receptor GFRh1 and implication of
GDNF in its neurotrophic role (Lenhard et al., 2002).
The present study, by showing a loss of induction of
BDNF and trkB mRNAs in FGF-2 null mice, proposes one
additional mechanism, by which FGF-2 might exert its
neuroprotective potential in brain ischemia, that is, through
an induction of BDNF and its receptor trkB. Although
FGF-2 has previously been shown to induce several
neurotrophic factors, including NGF (Yoshida and Gage,
1991) and GDNF (Suter-Crazzolara and Unsicker, 1996),
an inductive role of FGF-2 for BDNF has not been
reported as yet. BDNF is essential for development and
survival of several distinct neuron populations in vitro and
also in vivo, as shown by analyzing BDNF and trkB
knockout mice (Boyd and Gordon, 2001; Linnarsson et
al., 2000; see Conover and Yancopoulos, 1997, for re-
view). Moreover, beyond its classic trophic role, BDNF
plays an important role in the regulation of synaptic
plasticity (Kafitz et al., 1999; Korte et al., 1995). In the
context of its potential to ameliorate, the consequences of
cerebral ischemia (Beck et al., 1994; Scha ¨bitz et al., 1997;
Wu and Pardridge, 1999), both types of mechanisms could
be conceived to become effective. Specifically, BDNF has
also been shown to improve LTP and cognitive functions
after transient forebrain ischemia (Kiprianova et al., 1999).
While a causative relationship linking the neuroprotective
effect of FGF-2 in cerebral ischemia to the induction of
BDNF is conceivable, the existence of two correlative,
functionally unlinked phenomena cannot be excluded.
Moreover, even the FGF-2-BDNF link does not exclude
that lack of activation of other mechanisms attributed to
FGF-2 may account for the worsened outcome of cerebral
ischemia in FGF-2 null mice.
The main source of FGF-2 in the brain are astrocytes (for
review, see Reuss and von Bohlen und Halbach, 2003). It is
conceivable that FGF-2 ameliorating the outcome of ische-
mia directly signals from astroglial cells to adjacent neurons
activating FGF receptor-1 (FGFR1), the most prominent
FGFR on neurons (Yazaki et al., 1994). Damage of the
astroglial cell membrane due to the ischemic insult might
facilitate the release of FGF-2, which lacks a conventional
signal peptide and whose mode of release from cells has not
been clarified as yet. Alternatively, an indirect beneficial
role of FGF-2 is also conceivable, for example, by activat-
ing other mechanisms leading to neuronal survival.
In conclusion, our results support a prominent neuro-
protective role of endogenous FGF-2 in ischemic brain
injury. The loss of induction of BDNF and trkB mRNA in
ischemic FGF-2 null mice suggests that further exploration
of a trophic cascade implying FGF-2 and BDNF may yield
novel insights into the trophic signaling networks of the
CNS.
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